Related Experiment Video
Updated: Aug 19, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
[From gene to disease; PKHD1 and recessive polycystic kidney disease]
D J M Peters1, M Losekoot, C E M de Die-Smulders
1Afd. Humane Genetica, Leids Universitair Medisch Centrum, Centrum voor Humane en Klinische Genetica, Postbus 9600, 2300 RC Leiden.
Abstract:
Autosomal recessive polycystic kidney disease (ARPKD) is a severe form of polycystic kidney disease characterised by enlarged kidneys and congenital hepatic fibrosis. The disease has an incidence of 1:7000-:20,000 and is caused by mutations in the PKHD1 gene, which under normal conditions produces the protein fibrocystin, also named polyductin. This protein may be a transmembrane receptor or ligand that plays a role in collecting duct and biliary differentiation. The major site of expression is the primary cilium, and in particular the basal body of the cilium, underlining a link between aberrant cilial function and cystogenesis. Prenatal diagnostics is possible using DNA analysis or ultrasonography.
Related Concept Videos
Genetic Lingo
Pedigree Analysis
Nephrons
Pharmacogenomics: Identification of New Drug Targets
Sex-linked Disorders
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

